tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market
CRSP
Crispr Therapeutics AG
RESEARCH TOOLSreports
Want to see CRSP full AI Analyst Report?

Crispr Therapeutics AG (CRSP) Financial Statements

10,904 Followers

Crispr Therapeutics AG Financial Overview

Crispr Therapeutics AG's market cap is currently $4.70B. The company's EPS TTM is $-1.37; its P/E ratio is -8.11; Crispr Therapeutics AG is scheduled to report earnings on February 12, 2026, and the estimated EPS forecast is $-1.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 3.51M$ 35.00M$ 370.00M$ 436.00K$ 913.08M
Gross Profit$ -229.45M$ -75.25M$ 239.75M$ -109.81M$ 811.90M
Operating Income$ -568.32M$ -466.57M$ -222.54M$ -673.16M$ 373.53M
EBITDA$ -548.84M$ -447.31M$ -202.70M$ -648.99M$ 391.48M
Net Income$ -581.60M$ -366.25M$ -153.61M$ -650.17M$ 377.66M
Balance Sheet
Cash & Short-Term Investments$ 1.98B$ 1.90B$ 1.69B$ 1.82B$ 2.38B
Total Assets$ 2.27B$ 2.24B$ 2.23B$ 2.24B$ 2.75B
Total Debt$ 394.91M$ 223.69M$ 238.63M$ 244.02M$ 225.03M
Net Debt$ 39.73M$ -74.56M$ -150.84M$ 32.14M$ -698.00M
Total Liabilities$ 343.43M$ 309.95M$ 346.77M$ 367.58M$ 352.42M
Stockholders' Equity$ 1.92B$ 1.93B$ 1.88B$ 1.88B$ 2.40B
Cash Flow
Free Cash Flow$ -345.93M$ -144.68M$ -269.85M$ -532.93M$ 457.27M
Operating Cash Flow$ -345.01M$ -142.77M$ -260.38M$ -495.74M$ 538.97M
Investing Cash Flow$ -31.80M$ -280.48M$ 374.65M$ -258.65M$ -1.04B
Financing Cash Flow$ 426.03M$ 331.98M$ 62.66M$ 38.59M$ 250.94M
Currency in USD

Crispr Therapeutics AG Earnings and Revenue History

Income Statement >

Crispr Therapeutics AG Debt to Assets

Balance Sheet >

Crispr Therapeutics AG Cash Flow

Cash Flow >

Crispr Therapeutics AG Forecast EPS vs Actual EPS

Earnings >